Form 4 for DH Definitive Healthcare Corp.
Accepted 2025-02-04 00:00:00 ET · period of report 2025-01-21 · accession 0001415889-25-003033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-04 | 2025-01-21 | DH | Shamsuddin Kate Marie | COO | A - Grant | $0.00 | +56.2K | 483.7K | +13% | $0 | |
| M | 2025-02-04 | 2025-01-21+ | DH | Shamsuddin Kate Marie | COO | F - Tax | $4.75 | -21.7K | 462.1K | -4% | -$102.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-01-21 | A | A | 56,221 | $0.00 | 483,736 | D | — | — | (F1) Reflects the number of performance-based restricted stock units ("PSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, earned upon the certification of achievement of certain performance criteria by the Issuer's compensation committee. The PSUs will vest in three substantially equal installments as to 1/3rd on January 21, 2025, 1/3rd on February 1, 2026, and the remaining 1/3rd on February 1, 2027 and will be settled pursuant to the terms of the Issuer's 2021 Equity Incentive Plan (as amended from time to time), in each case subject to the Reporting Person's continued service with the Issuer through each such vesting date. |
| 2 | Common | Class A Common Stock | 2025-01-21 | F | D | 5,331 | $4.41 | 478,405 | D | — | — | |
| 3 | Common | Class A Common Stock | 2025-02-01 | F | D | 16,342 | $4.86 | 462,063 | D | — | — |